Sales to customers (Note 9)

Johnson & Johnson·Products & Services·37 segments·Rolls up to Total Revenue

Breakdown

Segment	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
DARZALEX	$2.88B	$3.02B	$3.08B	$3.24B	$3.54B	$3.67B	$3.90B	$3.96B
Other	$305.00M	$292.00M	$281.00M	$2.84B	$309.00M	$264.00M	$249.00M	$2.90B
Tremfya	$906.00M	$1.01B	$949.00M	$956.00M	$1.19B	$1.42B	$1.59B	$1.61B
GENERAL	$1.35B	$1.33B	$1.36B	$1.32B	$1.39B	$1.38B	$1.47B	$1.39B
ADVANCED	$1.14B	$1.11B	$1.15B	$1.07B	$1.16B	$1.17B	$1.18B	$1.12B
INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA	$1.05B	$1.05B	$1.06B	$903.00M	$992.00M	$929.00M	$986.00M	$1.04B
CONTACT LENSES / OTHER	$918.00M	$968.00M	$937.00M	$919.00M	$965.00M	$1.02B	$1.01B	$969.00M
ERLEADA	$736.00M	$790.00M	$784.00M	$771.00M	$908.00M	$936.00M	$959.00M	$949.00M
TRAUMA	$759.00M	$761.00M	$764.00M	$772.00M	$768.00M	$793.00M	$813.00M	$833.00M
SPINE & OTHER	$743.00M	$696.00M	—	$671.00M	$727.00M	$698.00M	—	$694.00M
IMBRUVICA	$770.00M	$753.00M	$731.00M	$709.00M	$735.00M	$695.00M	$684.00M	$660.00M
STELARA	$2.89B	$2.68B	$2.35B	$1.63B	$1.65B	$1.57B	$1.23B	$656.00M
SIMPONI / SIMPONI ARIA	$537.00M	$516.00M	$583.00M	$659.00M	$690.00M	$687.00M	$632.00M	$647.00M
XARELTO	$587.00M	$592.00M	$676.00M	$690.00M	$621.00M	$635.00M	$687.00M	$642.00M
OPSUMIT/OPSYNVI	—	—	—	$522.00M	$582.00M	$578.00M	—	$606.00M
CARVYKTI	$186.00M	$286.00M	$334.00M	$369.00M	$439.00M	$524.00M	$555.00M	$597.00M
UPTRAVI	$426.00M	$458.00M	$465.00M	$451.00M	$476.00M	$484.00M	$491.00M	$483.00M
SPRAVATO	$271.00M	$284.00M	$297.00M	$320.00M	$414.00M	$459.00M	$503.00M	$468.00M
PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA	$438.00M	$449.00M	$407.00M	$403.00M	$396.00M	$397.00M	$383.00M	$443.00M
HIPS	$417.00M	$381.00M	$418.00M	$409.00M	$421.00M	$405.00M	$439.00M	$436.00M
Remicade	$393.00M	$419.00M	$359.00M	$467.00M	$455.00M	$476.00M	$370.00M	$422.00M
KNEES	$394.00M	$352.00M	$398.00M	$389.00M	$389.00M	$377.00M	$432.00M	$420.00M
EDURANT/rilpivirine	$297.00M	$330.00M	$322.00M	$358.00M	$360.00M	$385.00M	$383.00M	$409.00M
SURGICAL	$367.00M	$333.00M	$365.00M	$361.00M	$403.00M	$383.00M	$411.00M	$396.00M
CAPLYTA	—	—	—	—	$211.00M	$240.00M	$249.00M	$270.00M
OTHER NEUROSCIENCE	$294.00M	$281.00M	$255.00M	$277.00M	$270.00M	$256.00M	$245.00M	$262.00M
RYBREVANT + LAZCLUZE	—	—	—	$141.00M	$179.00M	$198.00M	$216.00M	$257.00M
Tecvayli	$135.00M	$135.00M	$146.00M	$151.00M	$166.00M	$177.00M	$176.00M	$202.00M
Other Oncology	$83.00M	$86.00M	$75.00M	$214.00M	$93.00M	$94.00M	$100.00M	$192.00M
TALVEY	—	—	—	$86.00M	$106.00M	$122.00M	$149.00M	$152.00M
CONCERTA/Methylphenidate	$163.00M	$142.00M	$159.00M	$148.00M	$164.00M	$140.00M	$132.00M	$136.00M
OTHER IMMUNOLOGY	$2.00M	$1.00M	$0.00	$1.00M	$8.00M	$12.00M	$40.00M	$46.00M
OTHER INFECTIOUS DISEASES	$233.00M	$56.00M	$45.00M	$41.00M	$47.00M	$47.00M	$40.00M	$37.00M
ELECTROPHYSIOLOGY	$1.32B	$1.32B	$1.32B	$1.41B	$1.41B	$1.41B	$1.41B	—
other cardiovascular	—	—	—	$99.25M	$99.25M	$99.25M	$99.25M	—
SPINE,SPORTS & OTHER	$731.50M	$731.50M	$731.50M	$713.00M	$713.00M	$713.00M	$713.00M	—
Total	$22.45B	$22.47B	$22.52B	$21.89B	$23.74B	$23.99B	$24.56B	$24.06B

ELECTROPHYSIOLOGY, Abiomed, other cardiovascular, SPINE,SPORTS & OTHER are derived from annual filings.

Segments

CARVYKTIView metric

DARZALEXView metric

ERLEADAView metric

IMBRUVICAView metric

RYBREVANT + LAZCLUZEView metric

TALVEYView metric

TecvayliView metric

Other OncologyView metric

RemicadeView metric

SIMPONI / SIMPONI ARIAView metric

STELARAView metric

TremfyaView metric

OTHER IMMUNOLOGYView metric

CAPLYTAView metric

CONCERTA/MethylphenidateView metric

INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTAView metric

SPRAVATOView metric

OTHER NEUROSCIENCEView metric

OPSUMIT/OPSYNVIView metric

UPTRAVIView metric

OtherView metric

EDURANT/rilpivirineView metric

PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZAView metric

OTHER INFECTIOUS DISEASESView metric

XARELTOView metric

HIPSView metric

KNEESView metric

TRAUMAView metric

SPINE & OTHERView metric

ADVANCEDView metric

GENERALView metric

CONTACT LENSES / OTHERView metric

SURGICALView metric

ELECTROPHYSIOLOGYView metric

AbiomedView metric

other cardiovascularView metric

SPINE,SPORTS & OTHERView metric

Segment	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
DARZALEX	$2.88B	$3.02B	$3.08B	$3.24B	$3.54B	$3.67B	$3.90B	$3.96B
Other	$305.00M	$292.00M	$281.00M	$2.84B	$309.00M	$264.00M	$249.00M	$2.90B
Tremfya	$906.00M	$1.01B	$949.00M	$956.00M	$1.19B	$1.42B	$1.59B	$1.61B
GENERAL	$1.35B	$1.33B	$1.36B	$1.32B	$1.39B	$1.38B	$1.47B	$1.39B
ADVANCED	$1.14B	$1.11B	$1.15B	$1.07B	$1.16B	$1.17B	$1.18B	$1.12B
INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA	$1.05B	$1.05B	$1.06B	$903.00M	$992.00M	$929.00M	$986.00M	$1.04B
CONTACT LENSES / OTHER	$918.00M	$968.00M	$937.00M	$919.00M	$965.00M	$1.02B	$1.01B	$969.00M
ERLEADA	$736.00M	$790.00M	$784.00M	$771.00M	$908.00M	$936.00M	$959.00M	$949.00M
TRAUMA	$759.00M	$761.00M	$764.00M	$772.00M	$768.00M	$793.00M	$813.00M	$833.00M
SPINE & OTHER	$743.00M	$696.00M	—	$671.00M	$727.00M	$698.00M	—	$694.00M
IMBRUVICA	$770.00M	$753.00M	$731.00M	$709.00M	$735.00M	$695.00M	$684.00M	$660.00M
STELARA	$2.89B	$2.68B	$2.35B	$1.63B	$1.65B	$1.57B	$1.23B	$656.00M
SIMPONI / SIMPONI ARIA	$537.00M	$516.00M	$583.00M	$659.00M	$690.00M	$687.00M	$632.00M	$647.00M
XARELTO	$587.00M	$592.00M	$676.00M	$690.00M	$621.00M	$635.00M	$687.00M	$642.00M
OPSUMIT/OPSYNVI	—	—	—	$522.00M	$582.00M	$578.00M	—	$606.00M
CARVYKTI	$186.00M	$286.00M	$334.00M	$369.00M	$439.00M	$524.00M	$555.00M	$597.00M
UPTRAVI	$426.00M	$458.00M	$465.00M	$451.00M	$476.00M	$484.00M	$491.00M	$483.00M
SPRAVATO	$271.00M	$284.00M	$297.00M	$320.00M	$414.00M	$459.00M	$503.00M	$468.00M
PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA	$438.00M	$449.00M	$407.00M	$403.00M	$396.00M	$397.00M	$383.00M	$443.00M
HIPS	$417.00M	$381.00M	$418.00M	$409.00M	$421.00M	$405.00M	$439.00M	$436.00M
Remicade	$393.00M	$419.00M	$359.00M	$467.00M	$455.00M	$476.00M	$370.00M	$422.00M
KNEES	$394.00M	$352.00M	$398.00M	$389.00M	$389.00M	$377.00M	$432.00M	$420.00M
EDURANT/rilpivirine	$297.00M	$330.00M	$322.00M	$358.00M	$360.00M	$385.00M	$383.00M	$409.00M
SURGICAL	$367.00M	$333.00M	$365.00M	$361.00M	$403.00M	$383.00M	$411.00M	$396.00M
CAPLYTA	—	—	—	—	$211.00M	$240.00M	$249.00M	$270.00M
OTHER NEUROSCIENCE	$294.00M	$281.00M	$255.00M	$277.00M	$270.00M	$256.00M	$245.00M	$262.00M
RYBREVANT + LAZCLUZE	—	—	—	$141.00M	$179.00M	$198.00M	$216.00M	$257.00M
Tecvayli	$135.00M	$135.00M	$146.00M	$151.00M	$166.00M	$177.00M	$176.00M	$202.00M
Other Oncology	$83.00M	$86.00M	$75.00M	$214.00M	$93.00M	$94.00M	$100.00M	$192.00M
TALVEY	—	—	—	$86.00M	$106.00M	$122.00M	$149.00M	$152.00M
CONCERTA/Methylphenidate	$163.00M	$142.00M	$159.00M	$148.00M	$164.00M	$140.00M	$132.00M	$136.00M
OTHER IMMUNOLOGY	$2.00M	$1.00M	$0.00	$1.00M	$8.00M	$12.00M	$40.00M	$46.00M
OTHER INFECTIOUS DISEASES	$233.00M	$56.00M	$45.00M	$41.00M	$47.00M	$47.00M	$40.00M	$37.00M
ELECTROPHYSIOLOGY	$1.32B	$1.32B	$1.32B	$1.41B	$1.41B	$1.41B	$1.41B	—
other cardiovascular	—	—	—	$99.25M	$99.25M	$99.25M	$99.25M	—
SPINE,SPORTS & OTHER	$731.50M	$731.50M	$731.50M	$713.00M	$713.00M	$713.00M	$713.00M	—
Total	$22.45B	$22.47B	$22.52B	$21.89B	$23.74B	$23.99B	$24.56B	$24.06B

ELECTROPHYSIOLOGY, Abiomed, other cardiovascular, SPINE,SPORTS & OTHER are derived from annual filings.